Yubo International Biotech Ltd (YBGJ) stock: key figures, P/E, revenue and dividend

Health Care · China · ISIN US9883661004

Price
0.01 USD
Market cap
1.13 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Yubo International Biotech Ltd financials

Fiscal year2025
Revenue12,353.00 USD
Gross profit8,165.00 USD
Operating income-1.19 m USD
EBIT-1.19 m USD
Net income-1.08 m USD
Diluted EPS – continuing operations-0.01 USD

Full history since 2002, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Yubo International Biotech Ltd

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound drink/beverage; and facial care, eye care, and hair care series products. Yubo International Biotech Limited is headquartered in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.